Pfizer passes approval in Europe to expand use of XALKORI to first-line treatment of adults with ALK positive advanced non-small cell lung cancer

Perrigo to acquire United States rights for Entocort from AstraZeneca

US FDA approves Boehringer Ingelheim's Pradaxa

Phase II clinical trial for potential treatment of androgenetic alopecia completed by Samumed

Life Sciences Partners collaborates on immuno-oncology with Bristol-Myers Squibb

Arsanis initiates first cohort in Phase one clinical trial of ASN100

Impax introduces generic Avodart (Dutasteride) Capsules, 0.5 mg

Regeneron and Sanofi partnership announces full enrollment of 18,000 patient ODYSSEY OUTCOMES trial of Praluent Injection

Eli Lilly and Company wins US FDA's approval for Portrazza for first-line treatment of metastatic squamous non-small cell lung cancer

Mylan unveils generic FazaClo orally disintegrating tablets for treating schizophrenia

Xenios' i-cor Synchronized Cardiac Assist System Granted CE Mark

Peabody Named Chief Financial Officer at LifeMap Solutions

Active Implants Launches Clinical Trial of Implant for Persistent Knee Pain

Exosome Diagnostics Launches Clinical Commercialisation Programme

Air Techniques Expands the ProVecta X-ray Line